Type 2 diabetes, hypogonadism and testosterone therapy

Description


 

Speakers

Prof. Dr. Markolf Hanefeld

Prof. Dr. Markolf Hanefeld,
Dresden, Germany

References

  • Groti K, Zuran I, Antonic B, Forsnaric L, Pfeifer M. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes. The aging male : the official journal of the International Society for the Study of the Aging Male. 2018;21(3):158-169. Return to content